MA S749 | 2023-2024 | 193rd General Court

Note: Legislation replaced by S2492

Status

Spectrum: Moderate Partisan Bill (Democrat 12-2-1)
Status: Introduced on February 16 2023 - 25% progression
Action: 2023-10-30 - Accompanied a new draft, see S2492
Text: Latest bill text (Introduced) [PDF]

Summary

For legislation relative to pharmaceutical access, costs and transparency. Health Care Financing.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relative to pharmaceutical access, costs and transparency

Sponsors


History

DateChamberAction
2023-10-30SenateAccompanied a new draft, see S2492
2023-06-05JointHearing rescheduled to 06/06/2023 from 10:00 AM-04:00 PM in A-2
2023-06-02JointLocation Changed - Hearing scheduled for 06/06/2023 from 10:00 AM-04:00 PM in A-2
2023-05-23JointHearing scheduled for 06/06/2023 from 10:00 AM-01:00 PM in A-1
2023-02-16HouseHouse concurred
2023-02-16SenateReferred to the Joint Committee on Health Care Financing

Same As/Similar To

S2492 (Replaced by) 2023-11-15 - Read second
S2499 (Similar To) 2023-11-15 - Bills in the Third Reading report, substituting a new draft S2520, accepted
S2520 (Similar To) 2024-07-25 - Committee of conference appointed - (Lawn-F. Moran-Barrows), in concurrence

Massachusetts State Sources


Bill Comments

feedback